2024-04-11Zeitschriftenartikel
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024
Nørgaard, Sarah K.
Nielsen, Jens
Nordholm, Anne Christine
Richter, Lukas
Chalupka, Alena
Bustos Sierra, Natalia
Braeye, Toon
Athanasiadou, Maria
Lytras, Theodore
Denissov, Gleb
Luomala, Oskari
Fouillet, Anne
Pontais, Isabelle
an der Heiden, Matthias
Zacher, Benedikt
Weigel, Alina
Foppa, Ivo
Gkolfinopoulou, Kassiani
Panagoulias, Ioannis
Paldy, Anna
Malnasi, Tibor
Domegan, Lisa
Kelly, Eva
Rotem, Naama
Rakhlin, Oksana
de'Donato, Francesca K.
Di Blasi, Chiara
Hoffmann, Patrick
Velez, Telma
England, Kathleen
Calleja, Neville
van Asten, Liselotte
Jongenotter, Femke
Rodrigues, Ana Paula
Silva, Susana
Klepac, Petra
Gomez-Barroso, Diana
Leon Gomez, Inmaculada
Galanis, Ilias
Farah, Ahmed
Weitkunat, Rolf
Fehst, Katarina
Andrews, Nick
Clare, Tom
Bradley, Declan T.
O'Doherty, Mark G.
William, Naoma
Hamilton, Mark
Søborg, Bolette
Krause, Tyra G.
Bundle, Nick
Vestergaard, Lasse S.
Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.
Dateien zu dieser Publikation

